Research into neonatal disorders is complicated by heterogeneity. The variability in patient populations makes it difficult to conduct large-scale studies with consistent results. Additionally, rare disorders may have limited data available, hindering the development of evidence-based treatments. Collaborative research efforts and advanced technologies, such as genomics and machine learning, are essential for overcoming these challenges.